ACRSAclaris Therapeutics, Inc.May 7, 2024Q1 2024
Read transcript →Aclaris Therapeutics, Inc. (ACRS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$5.31
-3.45%
Mkt Cap $768.85M
ACRSAclaris Therapeutics, Inc.May 7, 2024ACRSAclaris Therapeutics, Inc.May 8, 2023Q1 2023
Read transcript →ACRSAclaris Therapeutics, Inc.Feb 25, 2020Q4 2019
Read transcript →ACRSAclaris Therapeutics, Inc.Nov 10, 2019Q3 2019
Read transcript →ACRSAclaris Therapeutics, Inc.Aug 9, 2019Q2 2019
Read transcript →ACRSAclaris Therapeutics, Inc.May 9, 2019Q1 2019
Read transcript →ACRSAclaris Therapeutics, Inc.Mar 18, 2019Q4 2018
Read transcript →ACRSAclaris Therapeutics, Inc.Nov 11, 2018Q3 2018
Read transcript →ACRSAclaris Therapeutics, Inc.Aug 3, 2018Q2 2018
Read transcript →ACRSAclaris Therapeutics, Inc.May 13, 2018Q1 2018
Read transcript →ACRSAclaris Therapeutics, Inc.Mar 12, 2018Q4 2017
Read transcript →ACRSAclaris Therapeutics, Inc.Nov 7, 2017Q3 2017
Read transcript →ACRSAclaris Therapeutics, Inc.Aug 11, 2017Q2 2017
Read transcript →ACRSAclaris Therapeutics, Inc.Mar 15, 2017Q4 2016
Read transcript →ACRSAclaris Therapeutics, Inc.Nov 3, 2016Q3 2016
Read transcript →